Top 5 Hepatology stories of the week

Numerous developments were made in the field of hepatology this week, therefore Healio.com/Hepatology compiled a list of the most read research and news in hepatology presented during the week.

Organovo's 3-D bioprinted liver effectively models drug-induced injury

Organovo researchers developed a 3-D bioprinted liver that effectively modeled drug-induced injury and discerned highly related compounds with different profiles, according to a study published in PLoS One. Read More

pSWE noninferior to transient elastography

Point quantification shear-wave elastography measured liver stiffness as accurately as transient elastography, according to recent findings published in Alimentary Pharmacology and Therapeutics. Read More

Meta-analysis reaffirms benefit of NADs in treating hepatic encephalopathy

A recent meta-analysis published in Hepatology reaffirmed the benefits of nonabsorbable disaccharides for treatment and prevention of both overt and minimal hepatic encephalopathy. Read more

Researchers develop index to better identify individuals with hepatic steatosis

Researchers developed a new score called the Framingham steatosis index that more accurately identified patients with hepatic steatosis, according to recent findings published in Clinical Gastroenterology and Hepatology. Read more

Alnylam announces phase 1/2 clinical trial of ALN-HBV RNA therapeutic

Alnylam Pharmaceuticals Inc. announced the initiation of its phase 1/2 clinical trial with ALN-HBV, a subcutaneously administered investigational RNA-interference therapeutic for the treatment of chronic hepatitis B virus infection. Read more